Recital 4, Regulation (EU) 2023/439

In forcesince 16 Dec 2022

Commission Implementing Regulation (EU) 2022/1160 [Commission Implementing Regulation (EU) 2022/1160 of 5 July 2022 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use and the specifications of the novel food nicotinamide riboside chloride (OJ L 179, 6.7.2022, p. 25).] authorised the use of nicotinamide riboside chloride in, among other products, foods for special medical purposes and total diet replacement for weight control for the adult population, excluding pregnant and lactating women, subject to certain conditions.